Pharmacodynamics focuses on the study of the action or effect of drugs in the body
Pharmacodynamics includes the study of the different effects of drugs when changing the dose or concentration
Pharmacodynamics involves the interaction of drugs with molecules in the body, specifically receptors
Receptors are molecules in the body that drugs bind to, leading to a series of physiological events and responses
Orphan receptors are receptors whose ligands are currently unknown, making them a target for new drug development
Most receptors in the body are regulatory proteins that, when bound by drugs, elicit physiological responses
Examples of substances that bind to regulatory proteins include neurotransmitters like nor epinephrine and acetylcholine
Neurotransmitters are produced by neurons and carry messages to different organs in the body
Hormones, another type of chemical messenger, are produced by glands like insulin from the pancreas and epinephrine from the adrenal medulla
Enzymes, although primarily involved in speeding up chemical reactions, can also act as drug receptors by being activated or inhibited by drugs
Examples of enzymes that interact with drugs include dihydrofolate reductase, which is inhibited by methotrexate
Cyclo-oxygenase (COX) enzymes are inhibited by NSAIDs like aspirin and ibuprofen, leading to the inhibition of inflammatory chemicals in the body
Transport proteins like the sodium-potassium ATPase pump regulate the exchange of sodium and potassium ions across cell membranes
Structural proteins like tubulin contribute to cell structure and can also be targeted by drugs as receptors
Excessive uric acid in the body, a degradation product of purines, can lead to conditions like gout due to deposits in joints causing pain and inflammation
Class one receptors, also known as ionotropic receptors, are located in the cell membrane and have a fast action when a drug binds to them, typically in milliseconds
Examples of class one receptors include nicotinic receptors, which are associated with ligand-gated ion channels
Nicotinic receptors are found in the cell membrane and when nicotine binds to them, the sodium ion channel opens, leading to the cell becoming more positive and active
Nicotinic receptors are stimulants of the central nervous system (CNS) as they make the cells more positive and active
GABA receptors, another type of class one receptor, when activated by GABA, open chloride channels causing the cell to become more negative and depressed in function
GABA stands for gamma amino butyric acid and is responsible for calming down the brain activity
Benzodiazepines (BZD) are examples of drugs that act on class one receptors to slow down the firing of neurons, used for anxiety and as hypnotics
Examples of benzodiazepines include alprazolam (Xanax) and diazepam (Valium)
Class two receptors, also known as metabotropic receptors, are also located in the cell membrane but have a slower effect compared to class one receptors, typically in seconds
G proteins are involved in the mechanism of action of class two receptors, with three types of G proteins: Gs, Gi, and Gq
Gs stimulates adenylyl cyclase enzyme to produce cyclic adenosine monophosphate (cAMP) as a secondary messenger
Gi inhibits adenylyl cyclase enzyme, leading to no cAMP production
Gq activates phospholipase C enzyme to produce inositol triphosphate (IP3) and diacylglycerol (DAG) as secondary messengers
Receptors can be proteins, including transport proteins, enzymes, and structural proteins
There are four subtypes of receptors
Class one receptors are ionotropic receptors, also known as ligand-gated receptors
Ligands binding to ionotropic receptors open ion channels, leading to depolarization of cells
Examples include nicotinic receptors and GABA receptors
Class two receptors are G protein-coupled receptors (metabotropic receptors)
These receptors are slower in their effects compared to class one receptors
Different types of G proteins include Gs (stimulate), Gi (inhibit), and Gq (activate phospholipase C)
G proteins lead to the production of secondary messengers like cAMP, IP3, and DAG
Class three receptors are enzyme-linked receptors
These receptors are much slower in their effects, taking minutes to hours to show an effect
Examples include epidermal growth factor and atrial natriuretic peptide (ANP)